Reducing Hereditary Cancer Act
Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · Jul 23, 2025
View full text on Congress.gov ↗ Policy area: Health
Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Source: Congressional Research Service (CRS).
Track HR 4752 in BallotBox360
Get real-time bill updates, floor vote alerts, and AI-powered summaries — all in one app.
Download on iOS Open Web App